US Broker Ratings

AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a Potential 249% Upside in the Biotech Sector

AtaiBeckley Inc. (ATAI), a clinical-stage biopharmaceutical company, stands at the forefront of mental health treatment innovation, boasting a market capitalization of $1.47 billion. Focused on developing breakthrough therapies for treatment-resistant..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Landscape with Potential Opportunities

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the healthcare sector, is capturing attention with its comprehensive suite of workforce solutions tailored for the medical care facilities industry...

Simulations Plus, Inc. (SLP): Investor Outlook with a 47% Potential Upside

Simulations Plus, Inc. (NASDAQ: SLP) is a key player in the healthcare sector, specifically within the health information services industry. Headquartered in Research Triangle Park, North Carolina, Simulations Plus leverages..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Potential Amidst Financial Challenges

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector, specifically within the medical care facilities industry, is garnering attention for its strategic positioning in the senior housing..

Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating the 42.92% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents an intriguing prospect for investors with its substantial potential upside. The company, which..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A Biotech Contender with 114% Upside Potential

Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of the investment community with its promising pipeline and substantial upside potential. Operating in..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A 135.75% Potential Upside for Investors in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline of cancer therapies and an enticing potential upside of 135.75% based on analyst target prices...

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 189% Upside for Investors

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with a staggering potential upside of 189.31%, according to the latest analyst ratings. Operating in the dynamic biotechnology industry, Verastem..

Claritev Corporation (CTEV) Stock Analysis: A Promising 64% Upside in Healthcare Tech

Claritev Corporation (NASDAQ: CTEV) is capturing the attention of investors with its significant potential upside, despite recent price fluctuations. The healthcare technology company, valued at $411.58 million, specializes in providing..

AbCellera Biologics Inc. (ABCL)

⚠️ No article content returned.

..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Biotech’s 121.89% Potential Upside Captivates Investors

In the dynamic landscape of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) emerges as a compelling opportunity for investors seeking high-growth potential in the healthcare sector. Boasting a market capitalization of..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenging Waters with a Pioneering Vision

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is currently navigating a complex market environment. With a market capitalization of $672.2 million, the company is..

Akso Health Group (AHG) Stock Analysis: A Closer Look at Market Position and Revenue Growth

Investors eyeing the healthcare sector may find Akso Health Group (NASDAQ: AHG) an intriguing prospect. With a market capitalization of $1.76 billion, this China-based company operates primarily in the medical..

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 38.97% Potential Upside in the Medical Devices Sector

For investors keen on the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a captivating opportunity within the medical devices industry. This Durham, North Carolina-based company is dedicated to innovating solutions..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Evaluating a Biotech with a 61% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention within the biotechnology sector, not just for its innovative approach to treating diseases with unmet medical needs but also for its compelling..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Navigating Growth Amidst a -0.14% Potential Downside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is a burgeoning player in the biotechnology sector, focusing on developing innovative treatments for pediatric and adult diseases. With a market capitalization of $2.22..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Promising 88% Upside in Healthcare Genomics

Personalis, Inc. (NASDAQ: PSNL), a pivotal player in the healthcare sector specializing in diagnostics and research, offers a compelling opportunity for investors intrigued by the burgeoning field of cancer genomics...

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations

PureTech Health plc (PRTC), a dynamic player in the biotechnology industry, is making waves with its innovative pipeline despite facing financial challenges. As a company based in Boston, Massachusetts, PureTech..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 234% Potential Upside

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at revolutionizing cancer treatment. Headquartered in San Diego, California, Kura..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds